USP14 inhibition led to a marked reduction in the tumor growth, augmented the infiltration of cytotoxic T cells, reduced the infiltration rate of Regulatory T cells (Tregs) and promoted the response to anti-PD-1 therapy [64]. This evidence concerns the gene USP14 and neoplasm.